FDA FluGuard+ coverage for business development, investment, and market access teams
The FDA has approved FluGuard+, a new vaccine designed to provide enhanced protection against emerging flu strains, improving public health outcomes.
We use cookies to enhance your experience, analyze traffic, and for marketing. By continuing to use our site, you consent to our use of cookies. Privacy Policy
